Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

[Diabetic kidney disease (Update 2019) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

Sourij H, Edlinger R, Prischl FC, Auinger M, Kaser S, Horn S, Paulweber B, Kautzky-Willer A, Säemann M, Prager R, Clodi M, Schernthaner G, Mayer G, Oberbauer R, Rosenkranz AR.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):151-163. doi: 10.1007/s00508-018-1425-x. German.

PMID:
30980144
2.

The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population.

Stapleton CP, Heinzel A, Guan W, van der Most PJ, van Setten J, Lord GM, Keating BJ, Israni AK, de Borst MH, Bakker SJL, Snieder H, Weale ME, Delaney F, Hernandez-Fuentes MP, Reindl-Schwaighofer R, Oberbauer R, Jacobson PA, Mark PB, Chapman FA, Phelan PJ, Kennedy C, Sexton D, Murray S, Jardine A, Traynor JP, McKnight AJ, Maxwell AP, Smyth LJ, Oetting WS, Matas AJ, Mannon RB, Schladt DP, Iklé DN, Cavalleri GL, Conlon PJ; UK Ireland Renal Transplant Consortium; DeKAF Genomics and GEN03 Studies; International Genetics and Translational Research in Transplantation Network.

Am J Transplant. 2019 Feb 27. doi: 10.1111/ajt.15326. [Epub ahead of print]

PMID:
30920136
3.

Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times.

Watschinger B, Budde K, Crespo M, Heemann U, Hilbrands L, Maggiore U, Mariat C, Oberbauer R, Oniscu GC, Peruzzi L, Sorensen SS, Viklicky O, Abramowicz D.

Nephrol Dial Transplant. 2019 Mar 4. pii: gfz026. doi: 10.1093/ndt/gfz026. [Epub ahead of print]

PMID:
30830155
4.

Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.

Reindl-Schwaighofer R, Heinzel A, Kainz A, van Setten J, Jelencsics K, Hu K, Loza BL, Kammer M, Heinze G, Hruba P, Koňaříková A, Viklicky O, Boehmig GA, Eskandary F, Fischer G, Claas F, Tan JC, Albert TJ, Patel J, Keating B, Oberbauer R; iGeneTRAiN consortium.

Lancet. 2019 Mar 2;393(10174):910-917. doi: 10.1016/S0140-6736(18)32473-5. Epub 2019 Feb 14.

PMID:
30773281
5.

How to increase kidney transplant activity throughout Europe-an advocacy review by the European Kidney Health Alliance.

Vanholder R, Stel VS, Jager KJ, Lameire N, Loud F, Oberbauer R, de Jong RW, Zoccali C.

Nephrol Dial Transplant. 2019 Jan 9. doi: 10.1093/ndt/gfy390. [Epub ahead of print]

PMID:
30629203
6.

Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working Group.

Maggiore U, Abramowicz D, Budde K, Crespo M, Mariat C, Oberbauer R, Pascual J, Peruzzi L, Schwartz Sorensen S, Viklicky O, Watschinger B, Oniscu GC, Heemann U, Hilbrands LB.

Nephrol Dial Transplant. 2019 Jan 9. doi: 10.1093/ndt/gfy391. [Epub ahead of print]

PMID:
30629182
7.

Steroid pretreatment of organ donors does not impact on early rejection and long-term kidney allograft survival: Results from a multicenter randomized, controlled trial.

Reindl-Schwaighofer R, Kainz A, Jelencsics K, Heinzel A, Berlakovich G, Remport Á, Heinze G, Langer R, Oberbauer R.

Am J Transplant. 2019 Jun;19(6):1770-1776. doi: 10.1111/ajt.15252. Epub 2019 Feb 1.

8.

Quality, quality, quality.

Wekerle T, Oberbauer R.

Transpl Int. 2019 Jan;32(1):5. doi: 10.1111/tri.13383. No abstract available.

PMID:
30569655
9.

2018 landmark papers in transplantation published in NDT: clinical research highlights in the area of kidney transplantation.

Oberbauer R.

Nephrol Dial Transplant. 2019 Mar 1;34(3):377-379. doi: 10.1093/ndt/gfy335. No abstract available.

PMID:
30428066
10.

A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

Vychytil A, Herzog R, Probst P, Ribitsch W, Lhotta K, Machold-Fabrizii V, Wiesholzer M, Kaufmann M, Salmhofer H, Windpessl M, Rosenkranz AR, Oberbauer R, König F, Kratochwill K, Aufricht C.

Kidney Int. 2018 Dec;94(6):1227-1237. doi: 10.1016/j.kint.2018.08.031. Epub 2018 Oct 22.

11.

Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.

Valent P, Büsche G, Theurl I, Uras IZ, Germing U, Stauder R, Sotlar K, Füreder W, Bettelheim P, Pfeilstöcker M, Oberbauer R, Sperr WR, Geissler K, Schwaller J, Moriggl R, Béné MC, Jäger U, Horny HP, Hermine O.

Haematologica. 2018 Oct;103(10):1593-1603. doi: 10.3324/haematol.2018.192518. Epub 2018 Aug 3. Review.

12.

Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.

Heinzel A, Kammer M, Mayer G, Reindl-Schwaighofer R, Hu K, Perco P, Eder S, Rosivall L, Mark PB, Ju W, Kretzler M, Gilmour P, Wilson JM, Duffin KL, Abdalla M, McCarthy MI, Heinze G, Heerspink HL, Wiecek A, Gomez MF, Oberbauer R; BEAt-DKD Consortium.

Diabetes Care. 2018 Sep;41(9):1947-1954. doi: 10.2337/dc18-0532. Epub 2018 Jul 6.

PMID:
29980527
13.

Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis.

Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sørensen SS, Dauber EM, Böhmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R.

Am J Transplant. 2019 Feb;19(2):475-487. doi: 10.1111/ajt.14970. Epub 2018 Jul 13.

PMID:
29900661
14.

Dialysis vintage and outcomes in renal transplantation.

Haller MC, Kammer M, Oberbauer R.

Nephrol Dial Transplant. 2019 Apr 1;34(4):555-560. doi: 10.1093/ndt/gfy099.

PMID:
29897595
15.

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators.

J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11.

PMID:
29752413
16.

NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD.

Snoek R, van Setten J, Keating BJ, Israni AK, Jacobson PA, Oetting WS, Matas AJ, Mannon RB, Zhang Z, Zhang W, Hao K, Murphy B, Reindl-Schwaighofer R, Heinzl A, Oberbauer R, Viklicky O, Conlon PJ, Stapleton CP, Bakker SJL, Snieder H, Peters EDJ, van der Zwaag B, Knoers NVAM, de Borst MH, van Eerde AM.

J Am Soc Nephrol. 2018 Jun;29(6):1772-1779. doi: 10.1681/ASN.2017111200. Epub 2018 Apr 13.

17.

Regression of left atrial diameter after kidney transplantation is associated with prolonged survival: an observational study.

Regele F, Kainz A, Kammer M, Beer A, Steringer-Mascherbauer R, Binder T, Oberbauer R.

Transpl Int. 2018 Mar 25. doi: 10.1111/tri.13152. [Epub ahead of print]

18.

Editorial for the March 2018 Focus Issue 'Omics in Transplantation'.

Oberbauer R.

Transpl Int. 2018 Mar;31(3):237-238. doi: 10.1111/tri.13136. No abstract available.

19.

Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.

Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA.

Am J Transplant. 2018 Sep;18(9):2261-2273. doi: 10.1111/ajt.14710. Epub 2018 Mar 30.

PMID:
29478298
20.

Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report.

Tong A, Sautenet B, Poggio ED, Lentine KL, Oberbauer R, Mannon R, Murphy B, Padilla B, Chow KM, Marson L, Chadban S, Craig JC, Ju A, Manera KE, Hanson CS, Josephson MA, Knoll G; SONG-Tx Graft Health Workshop Investigators.

Transplantation. 2018 Aug;102(8):1358-1366. doi: 10.1097/TP.0000000000002125.

PMID:
29470347
21.

Immunological consequences of kidney cell death.

Sarhan M, von Mässenhausen A, Hugo C, Oberbauer R, Linkermann A.

Cell Death Dis. 2018 Jan 25;9(2):114. doi: 10.1038/s41419-017-0057-9. Review.

22.

Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.

Abramowicz D, Oberbauer R, Heemann U, Viklicky O, Peruzzi L, Mariat C, Crespo M, Budde K, Oniscu GC.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1699-1707. doi: 10.1093/ndt/gfx365.

23.

Transplant International in a nutshell.

Wekerle T, Oberbauer R.

Transpl Int. 2018 Jan;31(1):5. doi: 10.1111/tri.13107. No abstract available.

24.

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Eskandary F, Regele H, Baumann L, Bond G, Kozakowski N, Wahrmann M, Hidalgo LG, Haslacher H, Kaltenecker CC, Aretin MB, Oberbauer R, Posch M, Staudenherz A, Handisurya A, Reeve J, Halloran PF, Böhmig GA.

J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.

25.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1959-1962. doi: 10.1093/ndt/gfx283. No abstract available.

PMID:
29099945
26.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C; European Renal, Cardiovascular Medicine (EURECA-m), the transplant DESCARTES working group of the European Renal Association-European Dialysis, Transplant Association (ERA-EDTA), the Working Group ‘Hypertension, Kidney’ of the European Society of Hypertension (ESH); the EKITA committee of the European Society of Organ Transplantation (ESOT), FCRIN INI-CRCT Cardiovascular, Renal Clinical Trialists.

J Hypertens. 2017 Dec;35(12):2335-2338. doi: 10.1097/HJH.0000000000001586. No abstract available.

PMID:
29095226
27.

An unjustified benefit: immortal time bias in the analysis of time-dependent events.

Gleiss A, Oberbauer R, Heinze G.

Transpl Int. 2018 Feb;31(2):125-130. doi: 10.1111/tri.13081. Epub 2017 Nov 9. Review.

28.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
29.

Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses.

Reindl-Schwaighofer R, Heinzel A, Signorini L, Thaunat O, Oberbauer R.

Transpl Int. 2018 Mar;31(3):239-250. doi: 10.1111/tri.13059. Epub 2017 Sep 28. Review.

30.

Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5.

Reindl-Schwaighofer R, Kainz A, Kammer M, Dumfarth A, Oberbauer R.

PLoS One. 2017 Jul 24;12(7):e0181345. doi: 10.1371/journal.pone.0181345. eCollection 2017.

31.

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.

Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC.

Transplantation. 2017 Aug;101(8):1875-1886. doi: 10.1097/TP.0000000000001776.

32.

Strategies for long-term preservation of kidney graft function.

Wekerle T, Segev D, Lechler R, Oberbauer R.

Lancet. 2017 May 27;389(10084):2152-2162. doi: 10.1016/S0140-6736(17)31283-7. Review.

PMID:
28561006
33.

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30. Review.

PMID:
28555652
34.

Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft Injury.

Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž.

Transplantation. 2017 May;101(5):e178-e187. doi: 10.1097/TP.0000000000001707.

PMID:
28252564
35.

Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group.

Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D; ERA-EDTA DESCARTES working group.

Nephrol Dial Transplant. 2017 Feb 1;32(2):216-223. doi: 10.1093/ndt/gfw429. Review.

PMID:
28186535
36.

Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes.

Mayer G, Heerspink HJ, Aschauer C, Heinzel A, Heinze G, Kainz A, Sunzenauer J, Perco P, de Zeeuw D, Rossing P, Pena M, Oberbauer R; SYSKID Consortium.

Diabetes Care. 2017 Mar;40(3):391-397. doi: 10.2337/dc16-2202. Epub 2017 Jan 11.

PMID:
28077457
37.

Steroid withdrawal after renal transplantation: a retrospective cohort study.

Haller MC, Kammer M, Kainz A, Baer HJ, Heinze G, Oberbauer R.

BMC Med. 2017 Jan 12;15(1):8. doi: 10.1186/s12916-016-0772-6.

38.

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.

Aschauer C, Perco P, Heinzel A, Sunzenauer J, Oberbauer R.

PLoS One. 2017 Jan 6;12(1):e0169518. doi: 10.1371/journal.pone.0169518. eCollection 2017.

39.

Never stand still.

Wekerle T, Oberbauer R.

Transpl Int. 2017 Jan;30(1):5. doi: 10.1111/tri.12908. No abstract available.

40.

Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.

Pichler G, Haller MC, Kainz A, Wolf M, Redon J, Oberbauer R.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1566-1578. doi: 10.1093/ndt/gfw387. Review.

PMID:
28025385
41.

Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.

Haller MC, Kainz A, Baer H, Oberbauer R.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):122-130. doi: 10.2215/CJN.04120416. Epub 2016 Nov 28.

42.

miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury.

Wilflingseder J, Jelencsics K, Bergmeister H, Sunzenauer J, Regele H, Eskandary F, Reindl-Schwaighofer R, Kainz A, Oberbauer R.

Am J Pathol. 2017 Jan;187(1):70-79. doi: 10.1016/j.ajpath.2016.09.011. Epub 2016 Nov 18.

PMID:
27870928
43.

Progression of Interstitial Fibrosis in Kidney Transplantation.

Oberbauer R.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2110-2112. Epub 2016 Oct 24. No abstract available.

44.

ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus.

Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F; ADHERE study investigators.

Transpl Int. 2017 Jan;30(1):83-95. doi: 10.1111/tri.12878. Epub 2016 Nov 28.

45.

Transplantation in Austria.

Berlakovich GA, Zuckermann A, Schneeberger S, Rosenkranz AR, Oberbauer R.

Transplantation. 2016 Sep;100(9):1785-7. doi: 10.1097/TP.0000000000001383. No abstract available.

PMID:
27542066
46.

Introducing the Wiley Transplant Peer Review Network.

Kirk AD, Malchesky PS, Shapiro R, Webber SA, Hirsch HH, Marty FM, Oberbauer R, Wekerle T, Bühler LH, Labbate A, Perry K, Wielgus J.

Am J Transplant. 2016 Sep;16(9):2505-7. doi: 10.1111/ajt.13965. Epub 2016 Aug 16. No abstract available.

47.

Criteria for and Appropriateness of Renal Transplantation in Elderly Patients With End-Stage Renal Disease: A Literature Review and Position Statement on Behalf of the European Renal Association-European Dialysis and Transplant Association Descartes Working Group and European Renal Best Practice.

Segall L, Nistor I, Pascual J, Mucsi I, Guirado L, Higgins R, Van Laecke S, Oberbauer R, Van Biesen W, Abramowicz D, Gavrilovici C, Farrington K, Covic A.

Transplantation. 2016 Oct;100(10):e55-65. doi: 10.1097/TP.0000000000001367. Review.

PMID:
27472096
48.

Introducing The Wiley Transplant Peer Review Network.

Kirk AD, Malchesky PS, Shapiro R, Webber SA, Hirsch HH, Marty FM, Oberbauer R, Wekerle T, Bühler LH, Labbate A, Perry K, Wielgus J.

Artif Organs. 2016 Jul;40(7):635-7. doi: 10.1111/aor.12772. No abstract available.

PMID:
27378614
49.

Immunosuppression in the elderly renal allograft recipient: a systematic review.

Montero N, Pérez-Sáez MJ, Pascual J; DESCARTES Working Group; DESCARTES ERA-EDTA Board:, Abramowicz D, Budde K, Dudley C, Hazzan M, Klinger M, Maggiore U, Oberbauer R, Pascual J, Sorensen SS, Viklicky O.

Transplant Rev (Orlando). 2016 Jul;30(3):144-53. doi: 10.1016/j.trre.2016.05.001. Epub 2016 May 20. Review.

PMID:
27279024
50.

Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.

Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.

Nephrol Dial Transplant. 2016 Aug;31(8):1342-51. doi: 10.1093/ndt/gfw027. Epub 2016 Mar 24.

PMID:
27190362

Supplemental Content

Loading ...
Support Center